The estimated Net Worth of Michael Alexander Smith is at least $15.5 Million dollars as of 12 August 2024. Mr Smith owns over 88,070 units of Insmed Inc stock worth over $12,863,750 and over the last 3 years he sold INSM stock worth over $2,653,819.
Mr has made over 13 trades of the Insmed Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 88,070 units of INSM stock worth $1,373,011 on 12 August 2024.
The largest trade he's ever made was exercising 88,070 units of Insmed Inc stock on 12 August 2024 worth over $1,373,011. On average, Mr trades about 8,433 units every 53 days since 2021. As of 12 August 2024 he still owns at least 176,797 units of Insmed Inc stock.
You can see the complete history of Mr Smith stock trades at the bottom of the page.
Michael Alexander Smith is the Sr. VP & Gen. Counsel at Insmed Inc.
Mr Smith is 44, he's been the Sr. VP & Gen. Counsel of Insmed Inc since . There are 21 older and 2 younger executives at Insmed Inc. The oldest executive at Insmed Inc is Steinar Engelsen, 70, who is the Independent Director.
Michael's mailing address filed with the SEC is 700 US HIGHWAY 202/206, , BRIDGEWATER, NJ, 08807.
Over the last 22 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis, and Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: